Statistics

Total Visits

Views
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a biomarker for the effect of PTK787/ZK 222584 as second-line mono-therapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC). 286

Total Visits per Month

April 2017 May 2017 June 2017 July 2017 August 2017 September 2017 October 2017
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a biomarker for the effect of PTK787/ZK 222584 as second-line mono-therapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC). 5 0 0 8 5 3 2

File Downloads

Views
dce-mri abstract.pdf 42

Top Country Views

Views
United States 65
Canada 48
France 46
United Kingdom 11
China 9
Russia 9
Germany 7
Sweden 6
Netherlands 5
Italy 3

Top City Views

Views
Miami Beach 23
Calgary 21
Toronto 12
Ottawa 9
Nynäs 6
Santa Clara 6
Zhengzhou 6
Kansas City 5
Dundas 3
Munich 3